SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Dec-19 9:56 PM View: | Vyne Therapeutics Inc. (VYNE) | 11-Dec-19 | Payment of Exercise | 27,766 | $4.52 | $125,502.00 | (35%) 80.3K to 52.53K | 61% |
13-Dec-19 9:56 PM View: | Vyne Therapeutics Inc. (VYNE) | 11-Dec-19 | Option Exercise | 80,300 | -- | -- | 100% 0 to 80.3K | |
02-Sep-16 12:25 PM View: | Relypsa Inc (RLYP) | 01-Sep-16 | Grant | 4,167 | -- | -- | 15% 28.11K to 32.28K | |
02-Sep-16 12:25 PM View: | Relypsa Inc (RLYP) | 01-Sep-16 | Disposition | 20,355 | $32.00 | $651,360.00 | (63%) 32.28K to 11.92K | |
02-Sep-16 12:25 PM View: | Relypsa Inc (RLYP) | 01-Sep-16 | Disposition (change in control) | 11,922 | $32.00 | $381,504.00 | (100%) 11.92K to 0 | |
17-Aug-16 4:21 PM View: | Relypsa Inc (RLYP) | 15-Aug-16 | Payment of Exercise | 1,480 | $31.89 | $47,197.20 | (5%) 29.59K to 28.11K | (< 1%) |
07-Jun-16 6:46 PM View: | Relypsa Inc (RLYP) | 03-Jun-16 | Grant | 2,083 | -- | -- | 7% 28.29K to 30.37K | |
07-Jun-16 6:46 PM View: | Relypsa Inc (RLYP) | 03-Jun-16 | Payment of Exercise | 783 | $19.96 | $15,628.70 | (3%) 30.37K to 29.59K | (1%) |
16-Mar-16 7:27 PM View: | Relypsa Inc (RLYP) | 16-Mar-16 | Market Purchase | 7,000 | $12.15 | $85,050.00 | 33% 21.29K to 28.29K | 7% |
10-Nov-15 9:51 PM View: | Relypsa Inc (RLYP) | 06-Nov-15 | Grant | 6,250 | -- | -- | 42% 15.04K to 21.29K | |
03-Sep-15 6:21 PM View: | Relypsa Inc (RLYP) | 02-Sep-15 | Market Sale (Planned) | 646 | $22.96 | $14,832.20 | (4%) 15.69K to 15.04K | (3%) |
19-Aug-15 7:40 PM View: | Relypsa Inc (RLYP) | 17-Aug-15 | Market Sale | 710 | $24.78 | $17,597.00 | (5%) 15.75K to 15.04K | 1% |
12-Aug-15 9:22 PM View: | Relypsa Inc (RLYP) | 10-Aug-15 | Grant | 8,250 | -- | -- | 110% 7.5K to 15.75K | |
05-Mar-15 8:24 PM View: | Relypsa Inc (RLYP) | 05-Mar-15 | Option Exercise | 3,000 | $3.96 | $11,880.00 | 40% 7.5K to 10.5K | |
05-Mar-15 8:24 PM View: | Relypsa Inc (RLYP) | 05-Mar-15 | Market Option Sale (Planned) | 2,481 | $41.00 | $101,721.00 | (24%) 10.5K to 8.02K | 2% |
05-Mar-15 8:24 PM View: | Relypsa Inc (RLYP) | 05-Mar-15 | Market Sale (Planned) | 519 | $41.00 | $21,279.00 | (6%) 8.02K to 7.5K | 2% |
05-Mar-15 8:24 PM View: | Relypsa Inc (RLYP) | 03-Mar-15 | Market Option Sale (Planned) | 519 | $38.80 | $20,137.20 | (6%) 8.02K to 7.5K | (3%) |
23-Jan-15 9:44 PM View: | Relypsa Inc (RLYP) | 21-Jan-15 | Option Exercise | 3,000 | $3.96 | $11,880.00 | 40% 7.5K to 10.5K | |
23-Jan-15 9:44 PM View: | Relypsa Inc (RLYP) | 21-Jan-15 | Market Option Sale (Planned) | 3,000 | $36.00 | $108,000.00 | (29%) 10.5K to 7.5K | (2%) |
18-Aug-14 6:52 PM View: | Relypsa Inc (RLYP) | 14-Aug-14 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
12-Nov-03 10:00 PM View: | Exelixis, Inc. (EXEL) | 12-Nov-03 | Market Sale | 4,674 | $7.01 | $32,779.70 | (49%) 9.59K to 4.91K | 13% |
12-Nov-03 10:00 PM View: | Exelixis, Inc. (EXEL) | 11-Nov-03 | Market Sale | 8,700 | $6.92 | $60,204.00 | (48%) 18.29K to 9.59K | 12% |